A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Clinical trial NCT06399757 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06399757
Sponsor: Apollo Therapeutics Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Cholangiocarcinoma Appendiceal Adenocarcinoma Pancreatic Adenocarcinoma Gastric Adenocarcinoma Endometrial Adenocarcinoma Triple Negative Breast Cancer Ovarian Cancer Prostate Cancer

Start date: 2024-06-18
Primary completion: 2027-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.